enquiry@riomed.com
+44 02380 277 044
New Hope for Lupus Patients: Breakthrough Research Offers Long-Term Solution
Dealing with lupus disease can be tough as the body’s immune system starts attacking healthy tissue in different parts of the body, from the skin and joints to essential organs like the kidneys, heart, and brain.
Did you know that around 5 million people worldwide are affected by lupus? It’s quite common in Australia, too, with about 1 in every 1,000 people being affected. Lupus mainly affects women, particularly during their childbearing years, usually between the ages of 15 and 45.
Symptoms of lupus disease can be tough to deal with, including fatigue, pain, swelling, and rashes. But there’s some good news – a new research study from Australia offers hope for a long-term solution. The study aims to help ease symptoms and improve the quality of life for people living with lupus disease.
What does the study say about the Lupus Disease?
Exciting news from the researchers at Monash University in Australia! They’ve made a big breakthrough in treating lupus disease. Their study, published in the prestigious journal Nature Communications, shows how they found a new way to reprogram the faulty cells of lupus patients using protective molecules from healthy individuals. Great news for lupus patients!
Over the course of six years, a study was carried out to focus on targeting specific human cells in lupus patients. The goal was to reprogram these cells using protective molecules to restore the immune system’s balance and prevent autoimmunity. Associate Professor Joshua Ooi explained that the method involved engineering regulatory T cells to inhibit the immune system’s harmful responses, resetting the abnormal immune system to a healthy state.
To conduct their research, the scientists took advantage of the amazing resources provided by the Australian Lupus Registry and Biobank, which were established at Monash University in 2012. By using cells from patients with lupus in test tubes and pre-clinical models with mice, they were able to show some promising results. What’s even better is that they did this without using any harmful drugs. They were able to stop the development of lupus kidney disease.
Co-senior author Professor Eric Morand is thrilled about how effective the treatment is. He mentioned that being able to target the disease-causing immune defect without suppressing the entire immune system is a great advancement in lupus treatment.
The next exciting step for the research team is to carry out clinical trials involving Australian lupus patients to confirm the effectiveness and safety of the method. Associate Professor Ooi is optimistic about the treatment’s potential, emphasizing its specificity and minimal side effects compared to traditional medications.
The study’s findings have gained attention from the scientific community, with experts acknowledging its potential to revolutionize autoimmune disease treatment.
Vu Nguyen established Lupus Victoria to provide support to fellow lupus patients. She herself has been living with the disease for almost three decades. But now, there’s hope for a long-term lupus treatment that can improve the quality of life for people like her. Vu feels optimistic about this treatment’s potential to reduce the need for multiple medications and help lupus patients become more independent.
As research on lupus disease moves forward, the scientific community is excited about the potential for new developments that could make a difference in treatment. With support from national and international agencies, including the Lupus Research Alliance, researchers are feeling optimistic about the impact these treatments could have on improving the lives of patients.
